Cargando…

Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study

INTRODUCTION: Children with the single-gene disorder neurofibromatosis type 1 (NF1) appear to be at an increased risk for autism spectrum disorder (ASD) and exhibit a unique social-cognitive phenotype compared with children with idiopathic ASD. A complete framework is required to better understand a...

Descripción completa

Detalles Bibliográficos
Autores principales: Haebich, Kristina M, Pride, Natalie A, Walsh, Karin S, Chisholm, Anita, Rouel, Melissa, Maier, Alice, Anderson, Vicki, Barton, Belinda, Silk, Tim, Korgaonkar, Mayuresh, Seal, Marc, Lami, Francesca, Lorenzo, Jennifer, Williams, Katrina, Dabscheck, Gabriel, Rae, Caroline D, Kean, Michael, North, Kathryn N, Payne, Jonathan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773330/
https://www.ncbi.nlm.nih.gov/pubmed/31558455
http://dx.doi.org/10.1136/bmjopen-2019-030601
_version_ 1783455880418689024
author Haebich, Kristina M
Pride, Natalie A
Walsh, Karin S
Chisholm, Anita
Rouel, Melissa
Maier, Alice
Anderson, Vicki
Barton, Belinda
Silk, Tim
Korgaonkar, Mayuresh
Seal, Marc
Lami, Francesca
Lorenzo, Jennifer
Williams, Katrina
Dabscheck, Gabriel
Rae, Caroline D
Kean, Michael
North, Kathryn N
Payne, Jonathan M
author_facet Haebich, Kristina M
Pride, Natalie A
Walsh, Karin S
Chisholm, Anita
Rouel, Melissa
Maier, Alice
Anderson, Vicki
Barton, Belinda
Silk, Tim
Korgaonkar, Mayuresh
Seal, Marc
Lami, Francesca
Lorenzo, Jennifer
Williams, Katrina
Dabscheck, Gabriel
Rae, Caroline D
Kean, Michael
North, Kathryn N
Payne, Jonathan M
author_sort Haebich, Kristina M
collection PubMed
description INTRODUCTION: Children with the single-gene disorder neurofibromatosis type 1 (NF1) appear to be at an increased risk for autism spectrum disorder (ASD) and exhibit a unique social-cognitive phenotype compared with children with idiopathic ASD. A complete framework is required to better understand autism in NF1, from neurobiological levels through to behavioural and functional outcomes. The primary aims of this study are to establish the frequency of ASD in children with NF1, examine the social cognitive phenotype, investigate the neuropsychological processes contributing to ASD symptoms and poor social functioning in children with NF1, and to investigate novel structural and functional neurobiological markers of ASD and social dysfunction in NF1. The secondary aim of this study is to compare the neuropsychological and neurobiological features of ASD in children with NF1 to a matched group of patients with idiopathic ASD. METHODS AND ANALYSIS: This is an international, multisite, prospective, cross-sectional cohort study of children with NF1, idiopathic ASD and typically developing (TD) controls. Participants will be 200 children with NF1 (3–15 years of age), 70 TD participants (3–15 years) and 35 children with idiopathic ASD (7–15 years). Idiopathic ASD and NF1 cases will be matched on age, sex and intelligence. All participants will complete cognitive testing and parents will rate their child’s behaviour on standardised questionnaires. Neuroimaging will be completed by a subset of participants aged 7 years and older. Children with NF1 that screen at risk for ASD on the parent-rated Social Responsiveness Scale 2nd Edition will be invited back to complete the Autism Diagnostic Observation Scale 2nd Edition and Autism Diagnostic Interview-Revised to determine whether they fulfil ASD diagnostic criteria. ETHICS AND DISSEMINATION: This study has hospital ethics approval and the results will be disseminated through peer-reviewed publications and international conferences.
format Online
Article
Text
id pubmed-6773330
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67733302019-10-21 Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study Haebich, Kristina M Pride, Natalie A Walsh, Karin S Chisholm, Anita Rouel, Melissa Maier, Alice Anderson, Vicki Barton, Belinda Silk, Tim Korgaonkar, Mayuresh Seal, Marc Lami, Francesca Lorenzo, Jennifer Williams, Katrina Dabscheck, Gabriel Rae, Caroline D Kean, Michael North, Kathryn N Payne, Jonathan M BMJ Open Paediatrics INTRODUCTION: Children with the single-gene disorder neurofibromatosis type 1 (NF1) appear to be at an increased risk for autism spectrum disorder (ASD) and exhibit a unique social-cognitive phenotype compared with children with idiopathic ASD. A complete framework is required to better understand autism in NF1, from neurobiological levels through to behavioural and functional outcomes. The primary aims of this study are to establish the frequency of ASD in children with NF1, examine the social cognitive phenotype, investigate the neuropsychological processes contributing to ASD symptoms and poor social functioning in children with NF1, and to investigate novel structural and functional neurobiological markers of ASD and social dysfunction in NF1. The secondary aim of this study is to compare the neuropsychological and neurobiological features of ASD in children with NF1 to a matched group of patients with idiopathic ASD. METHODS AND ANALYSIS: This is an international, multisite, prospective, cross-sectional cohort study of children with NF1, idiopathic ASD and typically developing (TD) controls. Participants will be 200 children with NF1 (3–15 years of age), 70 TD participants (3–15 years) and 35 children with idiopathic ASD (7–15 years). Idiopathic ASD and NF1 cases will be matched on age, sex and intelligence. All participants will complete cognitive testing and parents will rate their child’s behaviour on standardised questionnaires. Neuroimaging will be completed by a subset of participants aged 7 years and older. Children with NF1 that screen at risk for ASD on the parent-rated Social Responsiveness Scale 2nd Edition will be invited back to complete the Autism Diagnostic Observation Scale 2nd Edition and Autism Diagnostic Interview-Revised to determine whether they fulfil ASD diagnostic criteria. ETHICS AND DISSEMINATION: This study has hospital ethics approval and the results will be disseminated through peer-reviewed publications and international conferences. BMJ Publishing Group 2019-09-26 /pmc/articles/PMC6773330/ /pubmed/31558455 http://dx.doi.org/10.1136/bmjopen-2019-030601 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Paediatrics
Haebich, Kristina M
Pride, Natalie A
Walsh, Karin S
Chisholm, Anita
Rouel, Melissa
Maier, Alice
Anderson, Vicki
Barton, Belinda
Silk, Tim
Korgaonkar, Mayuresh
Seal, Marc
Lami, Francesca
Lorenzo, Jennifer
Williams, Katrina
Dabscheck, Gabriel
Rae, Caroline D
Kean, Michael
North, Kathryn N
Payne, Jonathan M
Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study
title Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study
title_full Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study
title_fullStr Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study
title_full_unstemmed Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study
title_short Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study
title_sort understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study
topic Paediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773330/
https://www.ncbi.nlm.nih.gov/pubmed/31558455
http://dx.doi.org/10.1136/bmjopen-2019-030601
work_keys_str_mv AT haebichkristinam understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT pridenataliea understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT walshkarins understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT chisholmanita understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT rouelmelissa understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT maieralice understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT andersonvicki understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT bartonbelinda understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT silktim understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT korgaonkarmayuresh understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT sealmarc understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT lamifrancesca understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT lorenzojennifer understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT williamskatrina understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT dabscheckgabriel understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT raecarolined understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT keanmichael understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT northkathrynn understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy
AT paynejonathanm understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy